These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8151009)

  • 21. Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.
    Sevincok L; Uslu A; Kaynak H; Dereboy F
    J Psychiatry Neurosci; 2000 Mar; 25(2):185. PubMed ID: 10740992
    [No Abstract]   [Full Text] [Related]  

  • 22. Controlled-release fluvoxamine in obsessive-compulsive disorder and social phobia.
    Owen RT
    Drugs Today (Barc); 2008 Dec; 44(12):887-93. PubMed ID: 19198698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
    Bogetto F; Bellino S; Vaschetto P; Ziero S
    Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ecchymoses as an adverse effect of fluvoxamine treatment in an adolescent girl.
    Vlatka BM; Branka AM; Branimir M
    Gen Hosp Psychiatry; 2010; 32(4):e9-e10. PubMed ID: 20633737
    [No Abstract]   [Full Text] [Related]  

  • 26. Seizures induced by combined levomepromazine-fluvoxamine treatment.
    Grinshpoon A; Berg Y; Mozes T; Mester R; Weizman A
    Int Clin Psychopharmacol; 1993; 8(1):61-2. PubMed ID: 8473723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.
    Goodman WK; Price LH; Rasmussen SA; Delgado PL; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1989 Jan; 46(1):36-44. PubMed ID: 2491940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of severe obsessive-compulsive disorder with fluvoxamine.
    Price LH; Goodman WK; Charney DS; Rasmussen SA; Heninger GR
    Am J Psychiatry; 1987 Aug; 144(8):1059-61. PubMed ID: 3111279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obsessive-compulsive disorder.
    George MS
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():57-66; discussion 66-8. PubMed ID: 1806635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluvoxamine withdrawal syndrome.
    Szabadi E
    Br J Psychiatry; 1992 Feb; 160():283-4. PubMed ID: 1540778
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluvoxamine in the treatment of compulsive buying.
    Black DW; Monahan P; Gabel J
    J Clin Psychiatry; 1997 Apr; 58(4):159-63. PubMed ID: 9164426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluvoxamine gains approval for obsessive-compulsive disorder.
    Am J Health Syst Pharm; 1995 Feb; 52(4):355. PubMed ID: 7757852
    [No Abstract]   [Full Text] [Related]  

  • 34. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
    Schaller JL; Behar D; Chamberlain T
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
    [No Abstract]   [Full Text] [Related]  

  • 36. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder.
    van Balkom AJ; de Haan E; van Oppen P; Spinhoven P; Hoogduin KA; van Dyck R
    J Nerv Ment Dis; 1998 Aug; 186(8):492-9. PubMed ID: 9717867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.
    Berigan TR; Harazin JS
    J Clin Psychiatry; 1996 Dec; 57(12):594-5. PubMed ID: 9010126
    [No Abstract]   [Full Text] [Related]  

  • 38. L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study.
    Arabzadeh S; Shahhossenie M; Mesgarpour B; Rezaei F; Shalbafan MR; Ghiasi Z; Akhondzadeh S
    Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28485008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hair loss associated with fluvoxamine use.
    Parameshwar E
    Am J Psychiatry; 1996 Apr; 153(4):581-2. PubMed ID: 8599419
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful fluvoxamine treatment of a case of refractory obsessive-compulsive disorder.
    Solyom L; Solyom CA
    Can J Psychiatry; 1990 Nov; 35(8):696-8. PubMed ID: 2126485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.